Trials / Completed
CompletedNCT02927795
OTIVACTO Spain Non Interventional Study
Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 257 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This is a self-controlled study design enrolling consented COPD patients who will be treated with Spiolto® Respimat® according to the approved SmPC. Patients will be enrolled consecutively and will be followed over an observational period of approx. 6 weeks.
Detailed description
Purpose: Study Design:
Conditions
Timeline
- Start date
- 2017-04-26
- Primary completion
- 2018-09-18
- Completion
- 2018-09-18
- First posted
- 2016-10-07
- Last updated
- 2019-09-30
- Results posted
- 2019-09-30
Locations
79 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02927795. Inclusion in this directory is not an endorsement.